Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gerritsen

Showing results (221-230 of 224) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 224 results.
Oncoimmunology|September 14, 2016
Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patientsSteve Boudewijns, Kalijn F Bol, Gerty Schreibelt, et al.
The New England Journal of Medicine|December 12, 2012
Abiraterone in metastatic prostate cancer without previous chemotherapyCharles J Ryan, Matthew R Smith, Johann S de Bono, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2015
Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic CellsGerty Schreibelt, Kalijn F Bol, Harm Westdorp, et al.
Nature Communications|February 23, 2024
Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trialKalijn F Bol, Gerty Schreibelt, Martine Bloemendal, et al.
Pageof 23

Showing results (221-230 of 224) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 224 results.
Oncoimmunology|September 14, 2016
Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patientsSteve Boudewijns, Kalijn F Bol, Gerty Schreibelt, et al.
The New England Journal of Medicine|December 12, 2012
Abiraterone in metastatic prostate cancer without previous chemotherapyCharles J Ryan, Matthew R Smith, Johann S de Bono, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2015
Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic CellsGerty Schreibelt, Kalijn F Bol, Harm Westdorp, et al.
Nature Communications|February 23, 2024
Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trialKalijn F Bol, Gerty Schreibelt, Martine Bloemendal, et al.
Pageof 23